-3.70 % to Target, BMO Capital Keeps ‘Buy’ Rating on Mylan Inc (NASDAQ:MYL) Shares Today

January 20, 2018 - By Michael Collier

  3.70 % to Target, BMO Capital Keeps ‘Buy’ Rating on Mylan Inc (NASDAQ:MYL) Shares Today

Investors sentiment decreased to 0.33 in Q3 2017. Its down 1.00, from 1.33 in 2017Q2. It dived, as 3 investors sold Mylan N.V. shares while 0 reduced holdings. 1 funds opened positions while 0 raised stakes. 155,019 shares or 7.99% less from 168,486 shares in 2017Q2 were reported.

Vantage Invest Advsrs Ltd Liability Corp reported 712 shares. Gulf Bank & Trust (Uk) Limited has invested 0.06% of its portfolio in Mylan N.V. (NASDAQ:MYL).

Mylan Inc (NASDAQ:MYL) Rating Reaffirmed

Research analysts at BMO Capital now has a $45.0 target on Mylan Inc (NASDAQ:MYL). BMO Capital and their recent target gives a potential downside of -3.70 % from the company’s close price. The rating has been shown in analysts note on 30 October.

Investors sentiment decreased to 0.33 in Q3 2017. Its down 1.00, from 1.33 in 2017Q2. It dived, as 3 investors sold Mylan N.V. shares while 0 reduced holdings. 1 funds opened positions while 0 raised stakes. 155,019 shares or 7.99% less from 168,486 shares in 2017Q2 were reported.

Vantage Invest Advsrs Ltd Liability Corp reported 712 shares. Gulf Bank & Trust (Uk) Limited has invested 0.06% of its portfolio in Mylan N.V. (NASDAQ:MYL).

Mylan N.V. (NASDAQ:MYL) Ratings Coverage

Among 21 analysts covering Mylan Inc. (NASDAQ:MYL), 13 have Buy rating, 0 Sell and 8 Hold. Therefore 62% are positive. Mylan Inc. has $85 highest and $3000 lowest target. $49.62’s average target is 6.18% above currents $46.73 stock price. Mylan Inc. had 62 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, August 19 by BTIG Research. The firm earned “Equal Weight” rating on Monday, September 21 by Barclays Capital. The stock of Mylan N.V. (NASDAQ:MYL) has “Strong Buy” rating given on Monday, October 10 by Raymond James. The rating was reinitiated by JP Morgan with “Overweight” on Wednesday, November 18. The firm has “Overweight” rating given on Monday, May 22 by Barclays Capital. Morgan Stanley maintained the stock with “Equal-Weight” rating in Friday, October 6 report. The stock of Mylan N.V. (NASDAQ:MYL) has “Hold” rating given on Thursday, December 21 by Cantor Fitzgerald. On Monday, October 23 the stock rating was maintained by Mizuho with “Buy”. The firm has “Hold” rating given on Thursday, August 27 by Zacks. The company was maintained on Friday, July 14 by RBC Capital Markets.

The stock increased 0.47% or $0.22 during the last trading session, reaching $46.73. About 7.89 million shares traded or 30.29% up from the average. Mylan N.V. (NASDAQ:MYL) has declined 7.73% since January 20, 2017 and is downtrending. It has underperformed by 24.43% the S&P500.

Analysts await Mylan N.V. (NASDAQ:MYL) to report earnings on March, 7. They expect $1.40 earnings per share, down 10.83 % or $0.17 from last year’s $1.57 per share. MYL’s profit will be $751.02 million for 8.34 P/E if the $1.40 EPS becomes a reality. After $1.10 actual earnings per share reported by Mylan N.V. for the previous quarter, Wall Street now forecasts 27.27 % EPS growth.

Mylan N.V., together with its subsidiaries, develops, licenses, makes, markets, and distributes generic, brand name, and over-the-counter products worldwide. The company has market cap of $25.07 billion. The firm operates through three divisions: North America, Europe, and Rest of World. It has a 28.9 P/E ratio. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

More recent Mylan N.V. (NASDAQ:MYL) news were published by: Bloomberg.com which released: “Generic-Drug Firms Fall as US Threatens to Sue for Damages” on January 19, 2018. Also Seekingalpha.com published the news titled: “Goldman rates Mylan tops in generic drug space, sees 14% upside; shares ahead 3%” on January 11, 2018. Streetinsider.com‘s news article titled: “Momenta Phama (MNTA), Mylan NV (MYL) Announce Development Strategy for M710” with publication date: January 03, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.